DMK Pharmaceuticals (DMK) has released an update to notify the public and investors about listing compliance status.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
DMK Pharmaceuticals Corporation’s common stock was suspended from trading on the Nasdaq Stock Market as of February 7, 2024. Following this suspension, the company is set to face delisting, with a formal notification to be filed with the U.S. Securities and Exchange Commission.
For further insights into DMK stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
